ResearcherUniversity Hospital Schleswig-HolsteinNo recent work listed

Tobias Bartscht

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-6149-465X; OpenAlex author ID A5010300198. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers

Papers 3

Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad si… Co-author DOI 10.1186/s12943-015-0468-0 ↗
Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. Co-author PMID 26124362 ↗
Metastatic spinal cord compression from pancreatic cancer. Last author PMID 24982394 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dirk Rades · 3 shared papers, 2014–2015 · strength 0.17
Louisa Bolm · 1 shared paper, 2015 · strength 0.06
- Paper Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. PMID 26124362 ↗
Ulrich Friedrich Wellner · 1 shared paper, 2015 · strength 0.06
- Paper Predicting Survival After Irradiation of Metastases from Pancreatic Cancer. PMID 26124362 ↗
Hendrik Lehnert · 1 shared paper, 2015 · strength 0.05
- Paper Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarci… DOI 10.1186/s12943-015-0468-0 ↗
Hendrik Ungefroren · 1 shared paper, 2015 · strength 0.05
- Paper Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarci… DOI 10.1186/s12943-015-0468-0 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.